154 related articles for article (PubMed ID: 31146616)
21. Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma.
Dehner CA; Armstrong AE; Yohe M; Shern JF; Hirbe AC
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680895
[TBL] [Abstract][Full Text] [Related]
22. A novel PAX3 rearrangement in embryonal rhabdomyosarcoma.
Hosoi H; Kakazu N; Konishi E; Tsuchihashi Y; Hada S; Amaya E; Nakabayahi Y; Misawa-Furihata A; Tabata-Maruyama H; Iehara T; Sugimoto T; Yamane H; Yamasaki M; Shiwaku K; Yanagisawa A; Ono M; Tokiwa K; Iwai N; Hashiba M; Abe T; Sawada T
Cancer Genet Cytogenet; 2009 Mar; 189(2):98-104. PubMed ID: 19215790
[TBL] [Abstract][Full Text] [Related]
23. Upstream CpG island methylation of the PAX3 gene in human rhabdomyosarcomas.
Kurmasheva RT; Peterson CA; Parham DM; Chen B; McDonald RE; Cooney CA
Pediatr Blood Cancer; 2005 Apr; 44(4):328-37. PubMed ID: 15602708
[TBL] [Abstract][Full Text] [Related]
24. Adult sclerosing rhabdomyosarcoma: cytogenetic link with embryonal rhabdomyosarcoma.
Croes R; Debiec-Rychter M; Cokelaere K; De Vos R; Hagemeijer A; Sciot R
Virchows Arch; 2005 Jan; 446(1):64-7. PubMed ID: 15660283
[TBL] [Abstract][Full Text] [Related]
25. A clinicopathologic study of head and neck rhabdomyosarcomas showing FOXO1 fusion-positive alveolar and MYOD1-mutant sclerosing are associated with unfavorable outcome.
Owosho AA; Huang SC; Chen S; Kashikar S; Estilo CL; Wolden SL; Wexler LH; Huryn JM; Antonescu CR
Oral Oncol; 2016 Oct; 61():89-97. PubMed ID: 27688110
[TBL] [Abstract][Full Text] [Related]
26. Detection of FOXO1 (FKHR) gene break-apart by fluorescence in situ hybridization in formalin-fixed, paraffin-embedded alveolar rhabdomyosarcomas and its clinicopathologic correlation.
Mehra S; de la Roza G; Tull J; Shrimpton A; Valente A; Zhang S
Diagn Mol Pathol; 2008 Mar; 17(1):14-20. PubMed ID: 18303411
[TBL] [Abstract][Full Text] [Related]
27. Rhabdomyosarcoma: From Obscurity to Clarity in Diagnosis … But With Ongoing Challenges in Management: The Farber-Landing Lecture of 2020.
Parham DM; Giannikopoulos P
Pediatr Dev Pathol; 2021; 24(2):87-95. PubMed ID: 33439112
[TBL] [Abstract][Full Text] [Related]
28. Alveolar rhabdomyosarcoma of the head and neck region in older adults: genetic characterization and a review of the literature.
Yasuda T; Perry KD; Nelson M; Bui MM; Nasir A; Goldschmidt R; Gnepp DR; Bridge JA
Hum Pathol; 2009 Mar; 40(3):341-8. PubMed ID: 18973919
[TBL] [Abstract][Full Text] [Related]
29. PAX immunoreactivity identifies alveolar rhabdomyosarcoma.
Sullivan LM; Atkins KA; LeGallo RD
Am J Surg Pathol; 2009 May; 33(5):775-80. PubMed ID: 19145202
[TBL] [Abstract][Full Text] [Related]
30. Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins.
Bernasconi M; Remppis A; Fredericks WJ; Rauscher FJ; Schäfer BW
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13164-9. PubMed ID: 8917562
[TBL] [Abstract][Full Text] [Related]
31. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.
Williamson D; Missiaglia E; de Reyniès A; Pierron G; Thuille B; Palenzuela G; Thway K; Orbach D; Laé M; Fréneaux P; Pritchard-Jones K; Oberlin O; Shipley J; Delattre O
J Clin Oncol; 2010 May; 28(13):2151-8. PubMed ID: 20351326
[TBL] [Abstract][Full Text] [Related]
32. Rhabdomyosarcoma: value of myogenin expression analysis and molecular testing in diagnosing the alveolar subtype: an analysis of 109 paraffin-embedded specimens.
Hostein I; Andraud-Fregeville M; Guillou L; Terrier-Lacombe MJ; Deminière C; Ranchère D; Lussan C; Longavenne E; Bui NB; Delattre O; Coindre JM
Cancer; 2004 Dec; 101(12):2817-24. PubMed ID: 15536621
[TBL] [Abstract][Full Text] [Related]
33. Investigation of PAX3/7-FKHR fusion genes and IGF2 gene expression in rhabdomyosarcoma tumors.
de Souza RR; Oliveira ID; Caran EM; Alves MT; Abib S; Toledo SR
Growth Horm IGF Res; 2012 Dec; 22(6):245-9. PubMed ID: 23079386
[TBL] [Abstract][Full Text] [Related]
34. A rapid one-generation genetic screen in a Drosophila model to capture rhabdomyosarcoma effectors and therapeutic targets.
Galindo KA; Endicott TR; Avirneni-Vadlamudi U; Galindo RL
G3 (Bethesda); 2014 Dec; 5(2):205-17. PubMed ID: 25491943
[TBL] [Abstract][Full Text] [Related]
35. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.
Sorensen PH; Lynch JC; Qualman SJ; Tirabosco R; Lim JF; Maurer HM; Bridge JA; Crist WM; Triche TJ; Barr FG
J Clin Oncol; 2002 Jun; 20(11):2672-9. PubMed ID: 12039929
[TBL] [Abstract][Full Text] [Related]
36. Expression of the retinoblastoma susceptibility gene in childhood rhabdomyosarcomas.
De Chiara A; T'Ang A; Triche TJ
J Natl Cancer Inst; 1993 Jan; 85(2):152-7. PubMed ID: 8418305
[TBL] [Abstract][Full Text] [Related]
37. PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells.
Tiffin N; Williams RD; Shipley J; Pritchard-Jones K
Br J Cancer; 2003 Jul; 89(2):327-32. PubMed ID: 12865925
[TBL] [Abstract][Full Text] [Related]
38. Alveolar rhabdomyosarcoma masquerading as embryonal subtype: the value of modern molecular diagnostic testing.
Eftekhari K; Chambers CB; Goldstein SM; Katowitz WR; Katowitz JA
Ophthalmic Plast Reconstr Surg; 2015; 31(2):e43-5. PubMed ID: 24608324
[TBL] [Abstract][Full Text] [Related]
39. Limits and chances in an unfortunate course of recurrent orbital rhabdomyosarcoma.
Rustemeyer J; Günther L; Junker K
Nepal J Ophthalmol; 2011; 3(2):202-5. PubMed ID: 21876600
[TBL] [Abstract][Full Text] [Related]
40. Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.
Parham DM; Qualman SJ; Teot L; Barr FG; Morotti R; Sorensen PH; Triche TJ; Meyer WH;
Am J Surg Pathol; 2007 Jun; 31(6):895-901. PubMed ID: 17527077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
